Risk factors and a predictive nomogram for lymph node metastasis of superficial esophagogastric junction cancer

被引:14
|
作者
Zhu, Min [1 ]
Cao, Bin [2 ]
Li, Xiao [1 ]
Li, Peng [1 ]
Wen, Zixian [3 ]
Ji, Jiafu [3 ]
Min, Li [1 ]
Zhang, Shutian [1 ]
机构
[1] Capital Med Univ, Beijing Key Lab Precancerous Les Digest Dis, Natl Clin Res Ctr Digest Dis,Dept Gastroenterol, Beijing Digest Dis Ctr,Beijing Friendship Hosp, Beijing 100050, Peoples R China
[2] Capital Med Univ, Ctr Endocrine Metab & Immune Dis, Beijing Key Lab Diabet Res & Care, Dept Endocrinol,Lu He Hosp, Beijing, Peoples R China
[3] Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Gastrointestinal Surg,Minist Educ, Beijing, Peoples R China
关键词
Esophagogastric junction cancer; Incidence; Lymph node metastasis; Nomogram; Risk factors; ENDOSCOPIC SUBMUCOSAL DISSECTION; TNM CLASSIFICATION; GASTRIC-CANCER; ADENOCARCINOMA; ESOPHAGEAL; EPIDEMIOLOGY; RECURRENCE; RESECTION; BARRETTS; EFFICACY;
D O I
10.1111/jgh.15004
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aim No predictive model for lymph node metastasis (LNM) of superficial esophagogastric junction (EGJ) cancer exists. This study aimed to evaluate incidence, identify risk factors, and develop a predictive nomogram for LNM in patients with superficial EGJ cancers. Methods Data were extracted from the Surveillance, Epidemiology, and End Results database for model development and internal validation. Another data set was obtained from two hospitals for external validation. A nomogram was developed based on independent risk factors that resulted from a multivariate logistic regression analysis. Internal and external validations were performed to assess the performance of nomogram model by receiver operating characteristic and calibration plot. Results Prevalence of LNM was 11.41% for intramucosal cancer and increased to 26.50% for submucosal cancer. On the multivariate analysis, large tumor size (odds ratio [OR] = 1.42;P < 0.001), moderately and poorly/un-differentiated pathological type (OR = 5.62 and 7.67;P = 0.024 and 0.008, respectively), and submucosal invasion (OR = 2.73;P = 0.004) were independent risk factors of LNM. The nomogram incorporating these three predictors demonstrated good discrimination (area under the estimated receiver operating characteristic curve [AUC]: 0.74; 95% confidence interval [95%CI]: 0.68, 0.80) and calibration (mean absolute error was 0.012). Moreover, the discrimination in the internal and external validation sets was good (AUC: 0.73 [95%CI: 0.66, 0.81] and 0.74 [95%CI: 0.60, 0.89], respectively). Nomogram provided better clinical usefulness as assessed by a decision curve analysis. Conclusions Prevalence of LNM in superficial EGJ cancer was high. The first risk-predictive nomogram model for LNM of superficial EGJ cancer may help clinicians to decide optimal treatment option preoperatively.
引用
收藏
页码:1524 / 1531
页数:8
相关论文
共 50 条
  • [1] LYMPH NODE METASTASIS RISK IN SUPERFICIAL ESOPHAGOGASTRIC JUNCTION ADENOCARCINOMA
    Akazawa, Naoki
    Horie, Yoshimasa
    Tamashiro, Atsuko
    Tokai, Yoshitaka
    Shiroma, Sho
    Nakano, Kaoru
    Namikawa, Ken
    Yoshimizu, Shoichi
    Horiuchi, Yusuke
    Ishiyama, Akiyoshi
    Yoshio, Toshiyuki
    Hirasawa, Toshiaki
    Tsuchida, Tomohiro
    Fujisaki, Junko
    [J]. GASTROINTESTINAL ENDOSCOPY, 2019, 89 (06) : AB476 - AB476
  • [2] Predictive Nomogram and Risk Factors for Lymph Node Metastasis in Bladder Cancer
    Tian, Zijian
    Meng, Lingfeng
    Wang, Xin
    Diao, Tongxiang
    Hu, Maolin
    Wang, Miao
    Zhang, Yaqun
    Liu, Ming
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [3] Risk factors and a predictive nomogram for lymph node metastasis in superficial esophageal squamous cell carcinoma
    Wang, Jin
    Zhang, Xian
    Gan, Tao
    Rao, Ni-Ni
    Deng, Kai
    Yang, Jin-Lin
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2023, 29 (47) : 6138 - 6147
  • [4] Patterns of the lymph node metastasis and the influencing factors in esophagogastric junction cancers
    Zhang, Dan
    Nan, Qiong
    [J]. ASIAN JOURNAL OF SURGERY, 2023, 46 (09) : 3512 - 3519
  • [5] Risk factors and prognosis in patients with adenocarcinoma of esophagogastric junction with lymph node metastasis of Siewert II/III
    Zheng, Zhi
    Shang, Yuxi
    Xu, Rui
    Zhang, Haiqiao
    Yin, Jie
    Zhang, Jun
    Zhang, Zhongtao
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2020, 13 (05): : 1262 - 1269
  • [6] Risk factors of lymph node metastasis or lymphovascular invasion for superficial esophageal squamous cell carcinoma: A practical and effective predictive nomogram based on a cancer hospital data
    Tao, Yali
    Chen, Shengsen
    Yu, Jiangping
    Shen, Qiwen
    Ruan, Rongwei
    Wang, Shi
    [J]. FRONTIERS IN MEDICINE, 2022, 9
  • [7] Risk Factors, Prognostic Factors, and Nomogram for Distant Metastasis in Breast Cancer Patients Without Lymph Node Metastasis
    Min, Yu
    Liu, Xiaoman
    Hu, Daixing
    Chen, Hang
    Chen, Jialin
    Xiang, Ke
    Yin, Guobing
    Han, Yuling
    Feng, Yang
    Luo, Haojun
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [8] Risk Factors and Prognostic Impact of Mediastinal Lymph Node Metastases in Patients with Esophagogastric Junction Cancer
    Osamu Shiraishi
    Takushi Yasuda
    Hiroaki Kato
    Mitsuru Iwama
    Yoko Hiraki
    Atsushi Yasuda
    Masayuki Shinkai
    Yutaka Kimura
    Motohiro Imano
    [J]. Annals of Surgical Oncology, 2020, 27 : 4433 - 4440
  • [9] Risk Factors and Prognostic Impact of Mediastinal Lymph Node Metastases in Patients with Esophagogastric Junction Cancer
    Shiraishi, Osamu
    Yasuda, Takushi
    Kato, Hiroaki
    Iwama, Mitsuru
    Hiraki, Yoko
    Yasuda, Atsushi
    Shinkai, Masayuki
    Kimura, Yutaka
    Imano, Motohiro
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (11) : 4433 - 4440
  • [10] Recurrence Pattern and Lymph Node Metastasis of Adenocarcinoma at the Esophagogastric Junction
    Suh, Yun-Suhk
    Lee, Kyung-Goo
    Oh, Seung-Young
    Kong, Seong-Ho
    Lee, Hyuk-Joon
    Kim, Woo-Ho
    Yang, Han-Kwang
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (12) : 3631 - 3639